1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Cancer/Tumor Profiling Industry 2015 Market Research Report

Global Cancer/Tumor Profiling Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 121 pages


The Global Cancer/Tumor Profiling Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cancer/Tumor Profiling industry.

The report provides a basic overview of the industry including definitions and classifications. The Cancer/Tumor Profiling market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 146 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Cancer/Tumor Profiling Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Basic Information of Cancer/Tumor Profiling
1.1.1 Definition of Cancer/Tumor Profiling
1.1.2 Classifications of Cancer/Tumor Profiling
1.1.2.1 NGS
1.1.2.2 QPCR
1.1.2.3 IHC
1.1.2.4 FISH/CISH
1.1.2.5 Microarray
1.1.3 Applications of Cancer/Tumor Profiling
1.1.3.1 Personalized Medicine
1.1.3.2 Diagnostics
1.1.3.3 Biomarker Discovery
1.1.3.4 Prognosis
1.1.3.5 Research
1.1.4 Characteristics of Cancer/Tumor Profiling
1.2 Development Overview of Cancer/Tumor Profiling
1.3 Enter Barriers Analysis of Cancer/Tumor Profiling

2 Cancer/Tumor Profiling International and China Market Analysis
2.1 Cancer/Tumor Profiling Industry International Market Analysis
2.1.1 Cancer/Tumor Profiling International Market Development History
2.1.2 Cancer/Tumor Profiling Competitive Landscape Analysis
2.1.3 Cancer/Tumor Profiling International Main Countries Development Status
2.1.4 Cancer/Tumor Profiling International Market Development Trend
2.2 Cancer/Tumor Profiling Industry China Market Analysis
2.2.1 Cancer/Tumor Profiling China Market Development History
2.2.2 Cancer/Tumor Profiling Competitive Landscape Analysis
2.2.3 Cancer/Tumor Profiling China Main Regions Development Status
2.2.4 Cancer/Tumor Profiling China Market Development Trend
2.3 Cancer/Tumor Profiling International and China Market Comparison Analysis

3 Environment Analysis of Cancer/Tumor Profiling
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Cancer/Tumor Profiling
3.4 News Analysis of Cancer/Tumor Profiling

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Cancer/Tumor Profiling by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Cancer/Tumor Profiling by Classifications 2010-2015
4.3 Cancer/Tumor Profiling Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Cancer/Tumor Profiling by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Cancer/Tumor Profiling
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Cancer/Tumor Profiling
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Cancer/Tumor Profiling
5.5 2010-2015 China Revenue and Revenue Growth Rate of Cancer/Tumor Profiling

6 Analysis of Cancer/Tumor Profiling Revenue Market Status 2010-2015
6.1 Revenue of Cancer/Tumor Profiling 2010-2015
6.2 Revenue Market Share Analysis of Cancer/Tumor Profiling 2010-2015
6.3 Revenue Overview of Cancer/Tumor Profiling 2010-2015
6.4 Gross Margin of Cancer/Tumor Profiling 2010-2015

7 Analysis of Cancer/Tumor Profiling Industry Key Manufacturers
7.1 Boreal Genomics
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Boreal Genomics SWOT Analysis

7.2 Caris Life Sciences
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Caris Life Sciences SWOT Analysis

7.3 Genomic Health
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Genomic Health SWOT Analysis

7.4 Illumina
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Illumina SWOT Analysis

7.5 Life Technologies
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Life Technologies SWOT Analysis

7.6 Neogenomics
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Neogenomics SWOT Analysis

7.7 Oxford Gene Technology
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 Oxford Gene Technology SWOT Analysis

7.8 Precision Therapeutics
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 Precision Therapeutics SWOT Analysis

7.9 Biotheranostics
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Biotheranostics SWOT Analysis

7.10 Proteome Sciences
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Proteome Sciences SWOT Analysis

7.11 Agendia
7.11.1 Company Profile
7.11.2 Revenue and Gross Margin
7.11.3 Agendia SWOT Analysis

7.12 Nanostring
7.12.1 Company Profile
7.12.2 Revenue and Gross Margin
7.12.3 Nanostring SWOT Analysis

7.13 Rational Therapeutics
7.13.1 Company Profile
7.13.2 Revenue and Gross Margin
7.13.3 Rational Therapeutics SWOT Analysis

7.14 Oncopath
7.14.1 Company Profile
7.14.2 Revenue and Gross Margin
7.14.3 Oncopath SWOT Analysis

7.15 Ribomed
7.15.1 Company Profile
7.15.2 Revenue and Gross Margin
7.15.3 Ribomed SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Cancer/Tumor Profiling
8.2 Gross Margin Analysis of Cancer/Tumor Profiling

9 Marketing Trader or Distributor Analysis of Cancer/Tumor Profiling
9.1 Marketing Channels Status of Cancer/Tumor Profiling
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Cancer/Tumor Profiling Industry 2016-2021
10.1 Revenue Overview of Cancer/Tumor Profiling 2016-2021
10.2 Sales Price Overview of Cancer/Tumor Profiling 2016-2021

11 Industry Chain Suppliers of Cancer/Tumor Profiling with Contact Information
11.1 Equipment Suppliers of Cancer/Tumor Profiling with Contact Information
11.2 Major Suppliers of Cancer/Tumor Profiling with Contact Information
11.3 Key Consumers of Cancer/Tumor Profiling with Contact Information
11.4 Supply Chain Relationship Analysis of Cancer/Tumor Profiling

12 New Project Investment Feasibility Analysis of Cancer/Tumor Profiling
12.1 New Project SWOT Analysis of Cancer/Tumor Profiling
12.2 New Project Investment Feasibility Analysis of Cancer/Tumor Profiling

13 Conclusion of the Global Cancer/Tumor Profiling Industry 2015 Market Research Report



List of Tables and Figures
Table Classifications of Cancer/Tumor Profiling
Table Applications of Cancer/Tumor Profiling
Table Policy of Cancer/Tumor Profiling
Table Industry News List of Cancer/Tumor Profiling
Table Global Revenue of Cancer/Tumor Profiling by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Cancer/Tumor Profiling by Classifications 2010-2015
Figure Global Revenue Market Share of Cancer/Tumor Profiling by Classifications in 2010
Figure Global Revenue Market Share of Cancer/Tumor Profiling by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Cancer/Tumor Profiling Revenue by Classifications
Table Europe Cancer/Tumor Profiling Revenue by Classifications
Table Japan Cancer/Tumor Profiling Revenue by Classifications
Table China Cancer/Tumor Profiling Revenue by Classifications
Table Global Revenue of Cancer/Tumor Profiling by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Cancer/Tumor Profiling by Regions 2010-2015
Figure Global Revenue Market Share of Cancer/Tumor Profiling by Regions in 2010
Figure Global Revenue Market Share of Cancer/Tumor Profiling by Regions in 2015
Table USA Cancer/Tumor Profiling Revenue by Applications
Figure USA Cancer/Tumor Profiling Revenue and Revenue Growth Rate
Table Europe Cancer/Tumor Profiling Revenue by Applications
Figure Europe Cancer/Tumor Profiling Revenue and Revenue Growth Rate
Table Japan Cancer/Tumor Profiling Revenue by Applications
Figure Japan Cancer/Tumor Profiling Revenue and Revenue Growth Rate
Table China Cancer/Tumor Profiling Revenue by Applications
Figure China Cancer/Tumor Profiling Revenue and Revenue Growth Rate
Table Global and China Major Players Cancer/Tumor Profiling Revenue of 2010-2015 (M USD)
Table Global and China Major Players Cancer/Tumor Profiling Revenue Market Share of 2010-2015
Table China Major Players Cancer/Tumor Profiling Revenue of 2010-2015 (M USD)
Table China Major Players Cancer/Tumor Profiling Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Cancer/Tumor Profiling Players in 2010
Figure Global Revenue Market Share of Major Cancer/Tumor Profiling Players in 2015
Figure China Revenue Market Share Major Cancer/Tumor Profiling Players in 2010
Figure China Revenue Market Share Major Cancer/Tumor Profiling Players in 2015
Figure Global Revenue and Growth Rate of Cancer/Tumor Profiling 2010-2015
Figure China Revenue and Growth Rate of Cancer/Tumor Profiling 2010-2015
Figure 2010-2015 Global and China Cancer/Tumor Profiling Revenue Comparison
Table Cost of Global Cancer/Tumor Profiling Major Players 2010-2015 (M USD)
Table Gross of Global Cancer/Tumor Profiling Major Players 2010-2015 (M USD)
Table Gross Margin of Global Cancer/Tumor Profiling Major Players 2010-2015
Figure Gross Margin of Global Cancer/Tumor Profiling Major Players in 2014
Table Company Profile List of Boreal Genomics
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Boreal Genomics 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Boreal Genomics 2010-2015
Table SWOT Analysis of Boreal Genomics 2010-2015
Table Company Profile List of Caris Life Sciences
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Caris Life Sciences 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Caris Life Sciences 2010-2015
Table SWOT Analysis of Caris Life Sciences 2010-2015
Table Company Profile List of Genomic Health
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Genomic Health 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Genomic Health 2010-2015
Table SWOT Analysis of Genomic Health 2010-2015
Table Company Profile List of Illumina
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Illumina 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Illumina 2010-2015
Table SWOT Analysis of Illumina 2010-2015
Table Company Profile List of Life Technologies
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Life Technologies 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Life Technologies 2010-2015
Table SWOT Analysis of Life Technologies 2010-2015
Table Company Profile List of Neogenomics
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Neogenomics 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Neogenomics 2010-2015
Table SWOT Analysis of Neogenomics 2010-2015
Table Company Profile List of Oxford Gene Technology
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Oxford Gene Technology 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Oxford Gene Technology 2010-2015
Table SWOT Analysis of Oxford Gene Technology 2010-2015
Table Company Profile List of Precision Therapeutics
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Precision Therapeutics 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Precision Therapeutics 2010-2015
Table SWOT Analysis of Precision Therapeutics 2010-2015
Table Company Profile List of Biotheranostics
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biotheranostics 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Biotheranostics 2010-2015
Table SWOT Analysis of Biotheranostics 2010-2015
Table Company Profile List of Proteome Sciences
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Proteome Sciences 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Proteome Sciences 2010-2015
Table SWOT Analysis of Proteome Sciences 2010-2015
Table Company Profile List of Agendia
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agendia 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Agendia 2010-2015
Table SWOT Analysis of Agendia 2010-2015
Table Company Profile List of Nanostring
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Nanostring 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Nanostring 2010-2015
Table SWOT Analysis of Nanostring 2010-2015
Table Company Profile List of Rational Therapeutics
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Rational Therapeutics 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Rational Therapeutics 2010-2015
Table SWOT Analysis of Rational Therapeutics 2010-2015
Table Company Profile List of Oncopath
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Oncopath 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Oncopath 2010-2015
Table SWOT Analysis of Oncopath 2010-2015
Table Company Profile List of Ribomed
Table Cancer/Tumor Profiling Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Ribomed 2010-2015
Figure Cancer/Tumor Profiling Revenue and Growth Rate of Ribomed 2010-2015
Table SWOT Analysis of Ribomed 2010-2015
Figure Cancer/Tumor Profiling Manufactor Profit Model
Figure Marketing Channels Status of Cancer/Tumor Profiling
Figure Global Revenue and Growth Rate of Cancer/Tumor Profiling 2016-2021
Figure China Revenue and Growth Rate of Cancer/Tumor Profiling 2016-2021
Figure Global and China Cancer/Tumor Profiling Revenue Comparison 2016-2021
Table Equipment Suppliers of Cancer/Tumor Profiling with Contact Information
Table Major Suppliers of Cancer/Tumor Profiling with Contact Information
Table Key Consumers of Cancer/Tumor Profiling with Contact Information
Figure Supply Chain Relationship Analysis of Cancer/Tumor Profiling
Table New Project SWOT Analysis of Cancer/Tumor Profiling

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.